Daily Judi: Tuesday, November 1, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The U.S. National Institutes of Health reports on a successful malaria antibody drug trial conducted in Mali, Africa.
Carly Page at TechCrunch details how MedCrypt, cybersecurity software company based in San Diego, California, landed a $25 million investment to protect medical devices.
KSAT News in San Antonio, Texas, features Dr. Sherwyn Schwartz and his team at Endeavor Clinical Trials, currently working on a groundbreaking COVID-19 vaccine.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“I’ve been at the company over seven years, and it’s been really cool to watch the company grow and continue to increase how we help our clients. One of the many things I like about my job is that it’s not always the same thing every day, because each client is unique. It makes every day interesting.
Judi is a platform. It’s an adjudication tool, but it’s also more. It’s a whole collaborative workflow process tool. It works with DSMB, Eligibility, anything.”
–Stephen, Lead Engineer
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
